Hancock Whitney Corp Regeneron Pharmaceuticals, Inc. Transaction History

Hancock Whitney Corp

  • $2.88 Billion
  • Q1 2024

A detailed history of Hancock Whitney Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 7,879 shares of REGN stock, worth $8.23 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
7,879
Previous 7,601 3.66%
Holding current value
$8.23 Million
Previous $6.68 Million 13.6%
% of portfolio
0.26%
Previous 0.25%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 16, 2024
BUY
$902.69 - $993.35 $250,947 - $276,151
278 Added 3.66%
7,879 $7.58 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $41,859 - $47,611
-54 Reduced 0.71%
7,601 $6.68 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $92,788 - $113,145
134 Added 1.78%
7,655 $6.3 Million
Q2 2023

Nov 13, 2023
SELL
$700.03 - $830.35 $501,221 - $594,530
-716 Reduced 8.69%
7,521 $5.4 Million
Q2 2023

Aug 10, 2023
SELL
$700.03 - $830.35 $501,221 - $594,530
-716 Reduced 8.69%
7,521 $5.4 Million
Q1 2023

Nov 13, 2023
SELL
$680.49 - $826.97 $482,467 - $586,321
-709 Reduced 7.93%
8,237 $6.77 Million
Q1 2023

May 16, 2023
SELL
$680.49 - $826.97 $482,467 - $586,321
-709 Reduced 7.93%
8,237 $6.77 Million
Q4 2022

Nov 13, 2023
BUY
$705.89 - $766.39 $1.01 Million - $1.09 Million
1,425 Added 18.95%
8,946 $6.45 Million
Q4 2022

Feb 03, 2023
BUY
$705.89 - $766.39 $141,178 - $153,278
200 Added 2.29%
8,946 $6.45 Million
Q3 2022

Oct 26, 2022
BUY
$573.97 - $724.32 $5.02 Million - $6.33 Million
8,746 New
8,746 $6.03 Million
Q1 2021

May 14, 2021
SELL
$446.73 - $548.2 $636,143 - $780,636
-1,424 Closed
0 $0
Q4 2020

Feb 09, 2021
SELL
$478.3 - $607.98 $27,741 - $35,262
-58 Reduced 3.91%
1,424 $688,000
Q3 2020

Nov 05, 2020
SELL
$544.75 - $658.21 $2,179 - $2,632
-4 Reduced 0.27%
1,482 $830,000
Q2 2020

Jul 30, 2020
SELL
$493.32 - $643.92 $5.31 Million - $6.93 Million
-10,755 Reduced 87.86%
1,486 $927,000
Q1 2020

May 08, 2020
SELL
$336.18 - $494.43 $1.38 Million - $2.03 Million
-4,113 Reduced 25.15%
12,241 $5.98 Million
Q4 2019

Feb 06, 2020
SELL
$274.13 - $376.51 $2.75 Million - $3.77 Million
-10,020 Reduced 37.99%
16,354 $6.14 Million
Q3 2019

Oct 29, 2019
SELL
$273.46 - $318.39 $363,701 - $423,458
-1,330 Reduced 4.8%
26,374 $7.32 Million
Q2 2019

Aug 29, 2019
SELL
$299.6 - $414.82 $171,071 - $236,862
-571 Reduced 2.02%
27,704 $8.67 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $2.55 Million - $3.01 Million
6,851 Added 31.98%
28,275 $11.6 Million
Q4 2018

Feb 15, 2019
SELL
$335.82 - $403.04 $3.14 Million - $3.77 Million
-9,360 Reduced 30.41%
21,424 $8 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $10.8 Million - $12.6 Million
30,784 New
30,784 $12.4 Million

Others Institutions Holding REGN

# of Institutions
1,426
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email